Seller record · Telehealth service
OurView Health
Fails 2 of 8 criteria. S2, prescription gating: The shop page sells GLP-1 injections at $75 and $135 and a GLP-1/GIP sublingual at $180 with buy now buttons, and the footer says payment does not guarantee a prescription. The about page instead lists a questionnaire and a physician's review before the purchase, and the answers say the buyer completes checkout and authorizes payment before the provider review. 1 more criterion also fails; see the table below.
At a glance
OurView HealthTelehealth service
- Price
- Semaglutide $109 a month, or $99 a month on a 3-month plan paid $297 up front; tirzepatide $129, or $119
- Sells
- compounded semaglutide, compounded tirzepatide, GLP-1/GIP sublingual, and 7 more
- FDA letters
- None on file
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A telehealth brand whose parent company runs its own compounding pharmacy, selling compounded semaglutide and tirzepatide at one price for every dose, sublingual GLP-1 blends, sermorelin, NAD+ and hormone therapy. Its shop page sells prescription GLP-1 injections with buy buttons, and its own pages print different prices for the same products.
Operating entity No legal entity name appears in the footer, in the terms and conditions, in the privacy policy or in the return and refund policy, which name the business only as OurView or Our View.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | OurView Health's about page; OurView Health's FAQ; OurView Health's personalized GLP-1 page |
| S2 | Prescription gating | FAIL | OurView Health's shop page; OurView Health's GLP-1 injection product page; OurView Health's about page; OurView Health's FAQ |
| S3 | Pharmacy identification | PASS | OurView Health's FAQ; OurView Health's return refund policy |
| S4 | Compounding disclosure | PASS | OurView Health's personalized GLP-1 page; OurView Health's is compounded semaglutide safe page; OurView Health's semaglutide page |
| S5 | Analytical documentation | FAIL | OurView Health's personalized GLP-1 page; OurView Health's FAQ; OurView Health's weight loss page |
| S6 | Business address | PASS | OurView Health's privacy policy; OurView Health's return refund policy; OurView Health's terms and conditions |
| S7 | Price disclosure | PASS | OurView Health's personalized GLP-1 page; OurView Health's personalized GLP-1 GIP page; OurView Health's shop page; OurView Health's sermorelin page; OurView Health's NAD+ page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, GLP-1/GIP sublingual, melatonin/GLP-1 sublingual, sermorelin, NAD+, lipo B12, testosterone cypionate, enclomiphene, bioidentical hormone therapy.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.